The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 3, 2013, Pages 497-503

  Shaw, Andrew D ^a   Kellum, John A ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; FLUID RESUSCITATION; HISTOLOGY; HUMAN; HYPOVOLEMIA; INCIDENCE; MORTALITY; NEPHROTOXICITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS;

ACUTE KIDNEY INJURY; EVIDENCE-BASED MEDICINE; FLUID THERAPY; HETASTARCH; HUMANS; INFUSIONS, INTRAVENOUS; PLASMA SUBSTITUTES; RISK ASSESSMENT; RISK FACTORS;

EID: 84875026364     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10921012     Document Type: Review

References (44)

1. Marik PE, Baram M, Vahid B: Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 134: 172-178, 2008
2. Wiesenack C, Prasser C, Rödig G, Keyl C: Stroke volume variation as an indicator of fluid responsiveness using pulse contour analysis in mechanically ventilated patients. Anesth Analg 96: 1254-1257, 2003
3. Préau S, Saulnier F, Dewavrin F, Durocher A, Chagnon JL: Passive leg raising is predictive of fluid responsiveness in spontaneously breathing patients with severe sepsis or acute pancreatitis. Crit Care Med 38: 819-825, 2010
4. Ernest D, Belzberg AS, Dodek PM: Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 27: 46-50, 1999
5. van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB: Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 37: 1275-1281, 2009
6. Wagner BK, D'Amelio LF: Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids, Part 1. Clin Pharm 12: 335-346, 1993
7. Chappell D, Westphal M, Jacob M: The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 22: 155-162, 2009
8. DeBackerD, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL: Microcirculatory alterations: Potential mechanisms and implications for therapy. Ann Intensive Care 1: 27, 2011
9. Hamilton MA, Cecconi M, Rhodes A: A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 112: 1392-1402, 2011
10. Prowle JR, Bellomo R: Fluid administration and the kidney. Curr Opin Crit Care 16: 332-336, 2010
11. Bagshaw SM, Bellomo R, Kellum JA: Oliguria, volume overload, and loop diuretics. Crit Care Med 36[Suppl]: S172-S178, 2008
12. Doherty M, Buggy DJ: Intraoperative fluids: How much is too much? Br J Anaesth 109: 69-79, 2012
13. Hiltebrand LB, Kimberger O, Arnberger M, Brandt S, Kurz A, Sigurdsson GH: Crystalloids versus colloids for goal-directed fluid therapy in major surgery. Crit Care 13: R40, 2009
14. Schortgen F, Deye N, Brochard L; CRYCO StudyGroup: Preferred plasma volume expanders for critically ill patients: Results of an international survey. Intensive Care Med 30: 2222-2229, 2004
15. Janssen CWJ Jr: Osmotic nephrosis. A clinical and experimental investigation. Acta Chir Scand 134: 481-487, 1968
16. Hüter L, Simon TP, Weinmann L, Schuerholz T, Reinhart K, Wolf G, Amann KU, Marx G: Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 13: R23, 2009
17. DickenmannM, Oettl T, Mihatsch MJ: Osmotic nephrosis: Acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51: 491-503, 2008
18. Ertmer C, Rehberg S, Van Aken H, Westphal M: Relevance of non-albumin colloids in intensive care medicine. Best Pract Res Clin Anaesthesiol 23: 193-212, 2009
19. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 357: 911-916, 2001
20. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, RagallerM, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358: 125-139, 2008
21. Eisenbach C, Schönfeld AH, Vogt N, Wente MN, Encke J, Stremmel W, Martin E, Pfenninger E, Weigand MA: Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: Influence of molecular weight and degree of substitution. Intensive Care Med 33: 1637-1644, 2007
22. Thomas G, Balk EM, Jaber BL: Effect of intensive insulin therapy and pentastarch resuscitation on acute kidney injury in severe sepsis. Am J Kidney Dis 52: 13-17, 2008
23. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL: Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98: 216-224, 2007
24. Magder S, Potter BJ, Varennes BD, Doucette S, Fergusson D; Canadian Critical Care Trials Group: Fluids after cardiac surgery: A pilot study of the use of colloids versus crystalloids. Crit Care Med 38: 2117-2124, 2010
25. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H: Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 16: R94, 2012
26. U.S. Food and Drug Administration. Voluven Package Insert. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/NewDrugApplicationsNDAs/UCM083138.pdf. Accessed January 3, 2013
27. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, FabritiusML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J; 6S Trial Group; Scandinavian Critical Care Trials Group: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 367: 124-134, 2012
28. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care SocietyClinical TrialsGroup:Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367: 1901-1911, 2012
29. KDIGO clinical practice guideline for acute kidney injury. Kidney Int [Suppl]: 1-138, 2012
30. Murugan R, Karajala-Subramanyam V, Lee M, Yende S, Kong L, Carter M, Angus DC, Kellum JA; Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators: Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 77: 527-535, 2010
31. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl JMed 345: 1368-1377, 2001
32. Kellum JA, Bellomo R, Kramer DJ, Pinsky MR: Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock 9: 364-368, 1998
33. Scheingraber S, Rehm M, Sehmisch C, Finsterer U: Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90: 1265-1270, 1999
34. Kellum JA, Song M, Almasri E: Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 130: 962-967, 2006
35. Kellum JA, Song M, Venkataraman R: Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 125: 243-248, 2004
36. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA: Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 255: 821-829, 2012
37. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308: 1566-1572, 2012
38. Wilcox CS: Regulation of renal blood flow by plasma chloride. J Clin Invest 71: 726-735, 1983
39. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247-2256, 2004
40. Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S; SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health: Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357: 874-884, 2007
41. Finfer S, McEvoy S, BellomoR, McArthurC, Myburgh J, Norton R; SAFE Study Investigators: Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37: 86-96, 2011
42. Perel P, Roberts I: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (3): CD000567, 2011
43. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354: 2564-2575, 2006
44. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL; Program to Improve Care in Acute Renal Disease (PICARD) Study Group: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76: 422-427, 2009